Multiple sclerosis: open trials in Latvia

• NCT07225504

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Novartis Investigative Site, Riga

  Registry updated 2026-10-13

• 2024-511686-11-00

  Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis

  Trial Treatment · Phase 3 · Novartis Pharma AG

  Bernu Kliniska Universitates Slimnica VSIA, Riga

  Registry updated 2026-09-29

• 2025-521546-23-00

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  Trial Treatment · Phase 3 · Novartis Pharma AG

  Pauls Stradins Clinical University Hospital, Riga

  Registry updated 2026-07-30

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error